Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Jade Biosciences, Inc. (JBIO) Institutional Ownership & Insider Trading

154 institutions reported holding Jade Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

JBIOJade Biosciences, Inc.Follow JBIO — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
927.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

154 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +38.0%.

Increased+59New+48Decreased-26Closed-13

Largest moves, shares (millions)

Paradigm Biocapital Advisors+2.9MFranklin Resources+2.8MFMR+2.0MAvidity Partners Management-1.1MGreat Point Partners-1.0MDriehaus Capital Management-0.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+1.2Sep 24+3.1Dec 24+0.9Mar 25+1.3Jun 25+0.1Sep 25+13.8Dec 25+4.2Mar 26+18.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2615473+38.0%59482613
Mar 2612051+9.3%39233313
Dec 2510547+43.6%4329155
Sep 257832+0.3%228223
Jun 257332+4.2%22242631
Mar 258232+3.1%257218
Dec 247930+11.7%24231318
Sep 247528+4.9%23111718

Jade Biosciences, Inc. — questions

Who owns Jade Biosciences, Inc. stock?
154 institutions reported Jade Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (14.3%), Jupiter Topco LLC (9.9%), Fairmount Funds Management LLC (7.2%).

Every figure on this page comes from Jade Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.